Studien

ACTS-GC

Adjuvant Chemotherapy trial of TS-1 for Gastric Cancer

ACTT-1

Adaptive COVID-19 Treatment Trial-1

ACTT-2

Adaptive COVID-19 Treatment Trial-2

ACTTION

Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks

ACTUALIZE

Evaluate the Safety and Treatment Pattern of Sodium Zirconium Cyclosilicate for Hyperkalaemia Management in Real World Practice in China

AcuDysg

Acupuncture in chemotherapy-induced dysgeusia

ACUITY

Acute Catheterization and Urgent Intervention Triage strategY trial

ACURASYS

ARDS et CURArisation SYStematique

ACURATE IDE

Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement

ACURATE neo2 PMCF

Outcomes and performance of the ACURATE neo2 transcatheter heart valve in clinical practice

ACUTE

Acute Congestive Heart Failure Urgent Care Evaluation

ACUTE

Analysis of Coronary Ultrasound Thrombolysis Endpoints in acute myocardial infarction

ACUTE

Assessment of Cardioversion Utilizing Transesophageal Echocardiography

ACUTE II

Antithrombotic Combination Using Tirofiban and Enoxaparin

ACUTE II

Assessment of Cardioversion Utilizing Transesophageal Echocardiography II

ACVC EAPCI EORP ACS STEMI

Association for Acute CardioVascular Care, European Association of Percutaneous Coronary Intervention, EurObservational programme, Acute Coronary Syndrome ST-Elevation Myocardial Infarction registry

AD ADOL

Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis

AD Up

A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

AD-Balloon

Multicenter Study of the Validity of Additional Freeze Cycles for Cryoballoon Ablation

AD2000

Alzheimer's Disease2000

ADACTA

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis

ADAD

Antipsychotic Discontinuation in Alzheimer Disease

ADAFI

Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease

ADAG

A1C-Derived Average Glucose

ADAGIO

A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease

ADAGIO

Attenuation of Disease progression with Azilect GIven Once-daily

ADAGIO-Lipids

Effect of Rimonabant on the High-Triglyceride/ low-HDL-cholesterol Dyslipidemia, Intraabdominal Adiposity, and Liver Fat

ADAM

Amsterdam Duration of Antiretroviral Medication study

ADAM

Aneurysm Detection And Management study

ADAM VTE

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

ADAPT

A 2hr Acceterared Diagnostik protocol to Assess patients with chest Pain symptoms using contemporary Troponins as the only biomarker

ADaPT

ACE inhibitor-based versus Diuretic-based Antihypertensive Primary Treatment in patients with pre-diabetes

ADAPT

Advancing Symptom Alleviation with Palliative Treatment

ADAPT

Alzheimer's Disease Anti-inflammatory Prevention Trial

ADAPT

An Efficacy and Safety Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness

ADAPT

Arthritis, Diet and Activity Promotion Trial

ADAPT

Assessment of Detemir Administration in Progressive Treat-to-Target Trial

ADAPT AF-DES

Appropriate Duration of Anti-Platelet and Thrombotic Strategy After 12 Months in Patients With Atrial Fibrillation Treated With Drug Eluting Stents

ADAPT TN

Adjuvante  dynamisch an Tumormarkern  adaptierte, personalisierte Therapiestudie, zur Optimierung von Risiko – Einschätzung und Vorhersage des Therapieansprechens bei Tripel-Negativem (TN) Brustkrebs

ADAPT Umbrella

Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer

ADAPT+

A Safety and Tolerability Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness

ADAPT-1

Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure-1

ADAPT-2

Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder

ADAPT-2

Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure-2

ADAPT-DES

Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents

ADAPT-DES IVUS

Comparison of plaque characteristics in narrowings with ST-elevation myocardial infarction (STEMI), non-STEMI/unstable angina pectoris and stable coronary artery disease

ADAPT-FS

Alzheimer's Disease Anti-Inflammatory Prevention Trial-Follow Up

ADAPT-PO

Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) Compared to Intravenous Ertapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

ADAPT-sepsis

Biomarker-guided duration of antibiotic treatment for sepsis

ADAPT-TAVR

Edoxaban Versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism After TAVR

ADAPT-TDM

A beta-lactam antibiotic Dose AdaPtation feasibility randomised controlled Trial using Therapeutic Drug Monitoring

ADAPTABLE

Aspirin Dosing: A Patient-centric Trial Assessing the Benefits and Long-term Effectiveness

AdaptResponse

Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure

ADAURA

AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy

ADAURA2

A Global Study to Assess the Effects of Osimertinib in Participants With EGFRm Stage IA2-IA3 NSCLC Following Complete Tumour Resection

ADCS

Alzheimer's Disease Cooperative Study

ADCT

Aldose Reductase Inhibitor-Diabetes Complications Trial

Add Health

National longitudinal study on Adolescent Health

ADD Study

Antiglucocorticoid augmentation (metyrapone) of antiDepressants in Depression

ADD-ASPIRIN

A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours